CVS HEALTH Corp Quarterly Amortization of Intangible Assets in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
CVS HEALTH Corp quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2012 to Q3 2024.
  • CVS HEALTH Corp Amortization of Intangible Assets for the quarter ending September 30, 2024 was $507M, a 0.39% decline year-over-year.
  • CVS HEALTH Corp Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $2.03B, a 12.8% increase year-over-year.
  • CVS HEALTH Corp annual Amortization of Intangible Assets for 2023 was $1.91B, a 6.72% increase from 2022.
  • CVS HEALTH Corp annual Amortization of Intangible Assets for 2022 was $1.79B, a 20.1% decline from 2021.
  • CVS HEALTH Corp annual Amortization of Intangible Assets for 2021 was $2.23B, a 4.61% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.03B $507M -$2M -0.39% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.03B $507M +$22M +4.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $2.01B $508M +$106M +26.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.91B $509M +$104M +25.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $1.8B $509M +$51M +11.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $1.75B $485M +$25M +5.44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.73B $402M -$60M -13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $1.79B $405M -$98M -19.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $1.88B $458M -$103M -18.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.99B $460M -$122M -21% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.11B $462M -$125M -21.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.23B $503M -$87M -14.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $2.32B $561M -$26M -4.43% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $2.35B $582M +$4M +0.69% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.34B $587M +$1M +0.17% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.34B $590M -$24M -3.91% Oct 1, 2020 Dec 31, 2020 8-K 2023-05-25
Q3 2020 $2.37B $587M -$20M -3.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $2.39B $578M -$15M -2.53% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $2.4B $586M -$36M -5.79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $2.44B $614M +$247M +67.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $2.19B $607M +$392M +182% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.8B $593M +$379M +177% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.42B $622M +$412M +196% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $1.01B $367M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $215M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $214M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $210M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q3 2014 $126M +$2M +1.61% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-04
Q3 2013 $124M +$3M +2.48% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q3 2012 $121M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.